News Column

inVentiv Health Initiates Refinancing Transactions To Fund Continued Growth

July 30, 2014

By a News Reporter-Staff News Editor at Biotech Week -- inVentiv Health, a life science knowledge and services company, announced that it has initiated a series of capital market transactions to fund continued growth (see also inVentiv Health, Inc.).

The transactions will extend debt maturities and substantially reduce cash interest expense. Funds affiliated with Thomas H. Lee Partners, L.P. and other existing investors will invest an additional $50 million of capital in inVentiv in connection with these transactions, consistent with their support of the company's strategy and growth prospects.

"These transactions reflect the strength of our service offering and business outlook, and allow inVentiv Health to invest in incremental growth opportunities and enhance our capabilities as a leading healthcare services provider to the global biopharmaceutical industry," said inVentiv Health CEO Paul Meister.

Keywords for this news article include: inVentiv Health, inVentiv Health Inc.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Biotech Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters